Exo Inc. (formerly MEDO DX Pte.)
About Exo Inc. (formerly MEDO DX Pte.)
Exo Inc. is a pioneering health information and medical devices company dedicated to modernizing medical imaging through its high-performance handheld ultrasound platform and artificial intelligence (AI). For physicians, Exo’s ecosystem aims to provide immediate, high-quality, and affordable medical answers at the point of care, enabling faster and more accurate diagnoses and treatment. The company’s technology integrates advanced nano-materials, novel sensor technologies, sophisticated signal processing, and computation with the scalability of semiconductor manufacturing to significantly reduce the cost and complexity of ultrasound imaging.
At the core of Exo’s offering is the Exo Iris handheld ultrasound device, complemented by a growing suite of FDA-cleared AI solutions and its award-winning POCUS workflow software, Exo Works®. The proprietary Sweep AI™ technology continuously evaluates and monitors ultrasound image quality, providing immediate feedback and indicating when sufficient diagnostic information has been captured. This technology, along with automated image acquisition and interpretation, radically lowers the expertise required to diagnose common and critical conditions, making point-of-care ultrasound more accessible to a wider range of caregivers.
Exo’s AI applications are rigorously trained on extensive datasets, including over 100,000 images from real-world POCUS exams, and are validated across diverse patient populations and health conditions. Currently, Exo has FDA 510k clearances for several applications, including cardiac (e.g., heart failure, hypertrophy), lung (e.g., B-lines, effusions, consolidations), bladder, hip dysplasia screening, and thyroid nodule assessments, with plans for further expansion. The Exo Works platform streamlines exam documentation, quality assurance, regulatory compliance, and billing processes, integrating seamlessly with various medical systems to enhance clinical workflows.
Focus Areas
Business Intelligence
| Key Investors | RA Capital Management, BlackRock, Sands Capital, Avidity Partners, Pura Vida Investments, Intel Capital, Sony Innovation Fund, Bold Capital Partners, Qubit Health Capital, OSF Healthcare, Applied Ventures, Creative Ventures, Action Potential Venture Capital, Nautilus Venture Partners, Rising Tide, Wanxiang America Corporation, Ferretto Capital, Fiscus Ventures, Reimagined Ventures (Magnetar Capital affiliates), HM Capital, Page One Ventures, Samsung Ventures |
| Partnerships | Samsung Medison (strategic collaboration for co-development and equity investment), Wellstar MCG Health (implementation of Exo Works), Henry Ford Health, Bill & Melinda Gates Foundation (grant for AI-enabled ultrasound in LMIC settings) |
| Acquisitions | Medo.AI (July 2022) |
| Technology | Silicon-based hardware, nano-materials, novel sensor technologies, advanced signal processing, tightly coupled AI, cloud-native workflow solution (Exo Works), AI Scan Tutor (Exo U), guided view capture (SweepAI) |
| FDA Clearances | 14 FDA-cleared AI indicators (for cardiac, lung, bladder, hip, thyroid applications) cleared products (estimated) |
What Physicians Need to Know
Exo Inc. stands out for physicians by offering a comprehensive POCUS ecosystem that prioritizes ease of use, speed, and accuracy. Their handheld Exo Iris device, powered by FDA-cleared AI (SweepAIu2122), allows for immediate diagnostic insights at the point of care, reducing the need to move patients and accelerating treatment decisions. The integrated Exo Worksu2122 workflow solution significantly cuts down on administrative tasks like documentation and billing by automatically saving to EMR and PACS, freeing up valuable physician time. Furthermore, Exo U provides on-demand educational support, making POCUS more accessible and reducing the learning curve for clinicians. The AI's ability to provide real-time feedback and interpretation helps to reduce operator dependence and increase diagnostic confidence, ultimately leading to improved patient outcomes and a more efficient clinical environment.
Exo's solutions, particularly Exo Worksu2122, are designed for seamless integration with existing healthcare IT infrastructure. They are compatible with any DICOM-enabled ultrasound machine and offer robust integration with EMR and PACS systems for streamlined data flow, archiving, and billing. Exo Works is Epic App Orchard certified and Cerner CODE program approved, ensuring broad compatibility within healthcare systems.
What the Web Says
Exo Inc., formerly MEDO DX Pte., appears to be a company with a strong focus on medical imaging technology, particularly in AI-powered ultrasound. While there is limited direct review data available from the specified platforms for 'Exo Inc.' or 'MEDO DX Pte.', the general sentiment around their technology seems to be positive, highlighting innovation in healthcare diagnostics. Employer reviews are scarce, making it difficult to assess company culture or employee satisfaction directly from the requested sources.
Overall: MixedStrengths
- Innovative AI-powered ultrasound technology
- Potential for improved diagnostic accuracy
- Focus on accessible and portable medical imaging
- Strong technological advancements in healthcare IT
Limitations
- Limited direct product reviews available on G2, Capterra
- Scarcity of employer reviews on Glassdoor
- Lack of specific user feedback on Reddit threads
- Relatively unknown in some review circles due to recent rebranding or niche market
Based on reviews from: G2 (limited data), Glassdoor (limited data), Capterra (limited data), Healthcare IT news articles and industry reports, Reddit (limited specific discussions)
Last updated: 2026-07-19
Videos
News, demos, and interviews about Exo Inc. (formerly MEDO DX Pte.).
Videos load interactively. If none appear, search YouTube for Exo Inc. (formerly MEDO DX Pte.) →
Press & Coverage
Frequently Asked Questions
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]